Abstract: An anode for a lithium secondary battery includes an anode current collector, and an anode active material layer formed on at least one surface of the anode current collector. The anode active material layer includes a carbon-based active material, a first silicon-based active material doped with magnesium and a second silicon-based active material not doped with magnesium. A content of the first silicon-based active material is in a range from 2 wt % to 20 wt % based on a total weight of the anode active material layer.

Abstract: Provided are a negative electrode for a lithium secondary negative electrode battery including: a current collector; a first negative electrode active material layer disposed on the current collector and including a silicon-based active material, a first graphite-based active material, and a linear conductive material; and a second negative electrode active material layer disposed on the first negative electrode active material layer and including a second graphite-based active material. The first graphite-based active material has a carbon coating layer on at least a part of a surface. Also provided is a lithium secondary battery including the negative electrode.

Abstract: The present disclosure is directed to a protein binding agent, or an antibody or an antigen-binding fragment thereof, which binds to a programmed death-1 (PD-1) protein. The present disclosure further provides a polynucleotide sequence encoding the protein binding agent, the antibody or the antigen-binding fragment thereof, a vector comprising the polynucleotide sequence, or a host cell comprising the vector. Also, the present disclosure provides a pharmaceutical composition or a kit, which comprises the protein binding agent, the antibody or the antigen-binding fragment thereof.

Abstract: An anode for a lithium secondary battery according to exemplary embodiments of the present disclosure includes: an anode current collector; an adhesive layer formed on the anode current collector and includes a first binder; and an anode active material layer formed on the adhesive layer and includes an anode active material including silicon-carbon composite particles and a second binder.

Abstract: An anode for a lithium secondary battery includes an anode current collector, and an anode active material layer formed on at least one surface of the anode current collector. The anode active material layer includes a carbon-based active material, a first silicon-based active material doped with magnesium and a second silicon-based active material not doped with magnesium. A content of the first silicon-based active material is in a range from 2 wt % to 20 wt % based on a total weight of the anode active material layer.

Abstract: One embodiment of the present invention provides: a high toughness high carbon cold rolled steel sheet having excellent formability comprising, by weight %, C: 0.80% to 1.25%, Mn: 0.2% to 0.6%, Si: 0.01% to 0.4%, P: 0.005% to 0.02%, S: 0.01% or less, Al: 0.01% to 0.1%, Cr: 0.01% to 1.0%, Sn: 0.05% to 0.5%, the remainder being Fe and other unavoidable impurities, in which a microstructure includes, by area %, retained austenite: 1% to 10%, martensite: 1% to 10%, ferrite: 5% or less (including 0%), the remainder being bainite, and has an average grain size of 3 ?m to 20 ?m, and an internal oxide layer formed directly below the surface has a thickness of 10 ?m or less; and a method for manufacturing same.

Abstract: The present application relates to a peptide having protective activity against cell damage caused by particulate matter, and to uses for the peptide.

Abstract: Provided are a peptide with a cytoprotective effect against environmental pollutants and a use thereof. The peptide consisting of an amino acid sequence of SEQ ID NO: 1, 2, or 3 directly binds to 2,3,7,8-tetrachlorodibenzo-p-dioxin (hereinafter, referred to as TCDD), known as being the most toxic among the class of dioxins, to prevent dermal penetration and the activation mechanism of AhR by TCDD and polycyclic aromatic hydrocarbons contained in fine dust. Such a direct cytoprotective effect against environmental pollutants is distinguished from preexisting methods that are configured to indirectly block opportunities to contact these materials or to reduce toxicity through barrier reinforcement.

Abstract: A method for a first user terminal to use a messenger service of a group chat room is proposed. The method may include receiving, from a server, invitation information associated with a second user's inviting a first user to the group chat room, and displaying chat room information on the group chat room. The method may also include in response to the second user not being registered as a friend of the first user in the messenger service, displaying information on the second user and an interface for deciding whether to participate in the group chat room. The method may further include acquiring an interaction regarding a decision to participate in the group chat room through the interface, and displaying a message created in the group chat room.

Abstract: An electrode for a secondary battery includes a current collector, a first electrode mixture layer disposed on at least one surface of the current collector and including carboxymethyl cellulose and styrene butadiene rubber, and a second electrode mixture layer disposed on the first electrode mixture layer and including carboxymethyl cellulose. A weight average molecular weight of the carboxymethyl cellulose included in the first electrode mixture layer is less than a weight average molecular weight of the carboxymethyl cellulose included in the second electrode mixture layer. Adhesion between the electrode current collector and the active material and cohesion between the active materials may be improved, and the resistance within the electrode may be reduced, thereby significantly increasing the capacity and lifespan characteristics of a battery.

Abstract: Provided are a novel Lactiplantibacillus plantarum BNT_G401 strain and uses thereof. A method for manufacturing a ?-aminobutyric acid (GABA) containing fermented product includes (a) dissolving in water a Curcuma longa L. extract having a solid content of 0.5 to 10%; monosodium glutamate (MSG); a carbon source; and a nitrogen source, and sterilizing the same to manufacture a medium composition; (b) inoculating the medium composition with a Lactiplantibacillus plantarum strain; and (c) fermenting the medium composition in which the strain is inoculated to manufacture a GABA containing fermented product.

Abstract: Disclosed is a parallel processor. The parallel processor includes a processing element array including a plurality of processing elements arranged in rows and columns, a row memory group including row memories corresponding to rows of the processing elements, a column memory group including column memories corresponding to columns of the processing elements, and a controller to generate a first address and a second address, to send the first address to the row memory group, and to send the second address to the column memory group. The controller supports convolution operations having mutually different forms, by changing a scheme of generating the first address.

Abstract: The present invention relates to a biocompatible film that exhibits high tensile strength and has biocompatibility and elastic properties, enabling its efficient use in the treatment or protection of human organs. The present invention also relates to a method for producing the biocompatible film.

Abstract: The present invention relates to an antibody having enhanced binding affinity for human Fc alpha receptor and a technique for maximizing a mechanism of antibody action by using same. Antibodies specific for Fc alpha receptors or immunologically active fragments thereof according to the present invention are in the form of IgG and bind to Fc alpha receptors of effector cells, especially, neutrophils, which are most abundant in mammals, thereby overcoming the disadvantages of conventional IgA antibodies and maximizing an effector function in various antibody therapeutic agents, which leads to maximizing the mechanism of antibody action (ADCC and ADCP). Thus, various Fc-fused protein therapeutic agents using same can be advantageously utilized as antibody drugs with enhanced effector functions.

Abstract: The present invention relates to a method of improving the quality of therapeutic cells by real-time glutathione monitoring.

Abstract: The polyethylene according to the present disclosure reacts with chlorine to prepare a chlorinated polyethylene having excellent processability during extrusion with a high tensile strength by implementing a molecular structure having a high content of medium molecular weight, and may also prepare a CPE compound including the chlorinated polyethylene.

Abstract: An anode for a lithium secondary battery includes an anode current collector, and a first anode active material layer and a second anode active material layer sequentially stacked on a surface of the anode current collector. Each of the first anode active material layer and the second anode active material layer includes an anode active material and a binder. A content of a free binder unbonded with the anode active material in the first anode active material layer based on a weight of the binder included in the first anode active material layer is greater than a content of a free binder unbonded with the anode active material in the second anode active material layer based on a weight of the binder included in the second anode active material layer.

Abstract: Embodiments herein describe an integrated circuit that includes a NoC with at least two levels of switching: a sparse network and a non-blocking network. In one embodiment, the non-blocking network is a localized interconnect that provides an interface between the sparse network in the NoC and a memory system that requires additional bandwidth such as HBM2/3 or DDR5. Hardware elements connected to the NoC that do not need the additional benefits provided by the non-blocking network can connect solely to the sparse network. In this manner, the NoC provides a sparse network (which has a lower density of switching elements) for providing communication between lower bandwidth hardware elements and a localized non-blocking network for facilitating communication between the sparse network and higher bandwidth hardware elements.

Abstract: The present invention relates to a particulate nano-lipid carrier for the encapsulation of a bioactive material, and a method for producing same, and more specifically, to a particulate nano-lipid carrier having excellent nanoparticle stability and improved encapsulation of water-soluble drugs. A nano-lipid carrier according to the present invention has significantly improved bioactive material stability and encapsulation efficiency compared to conventional carriers, and it is anticipated that the nano-lipid carrier according to the present invention will be immediately commercializable as a raw material for cosmetics by means of a hair follicle targeting production method suitable for mass production.

Abstract: In some implementations, the anode includes a current collector, a first anode mixture layer formed on at least one surface of the current collector, and a second anode mixture layer formed on the first anode mixture layer. The first anode mixture layer and the second anode mixture layer include a carbon-based active material, respectively. The first anode mixture layer includes a first binder, a first silicon-based active material, and a first conductive material. The second anode mixture layer includes a second binder, a second silicon-based active material, and a second conductive material. Contents of the first conductive material and the second conductive material are different from each other with respect to the total combined weight of the first anode mixture layer and the second anode mixture layer. Types of the first silicon-based active material and the second silicon-based active material are different from each other.